Evidence map›Paper›PMID 24016073›Full record

ArticleNano letters2013

Are bidentate ligands really better than monodentate ligands for nanoparticles?

Hiroko Takeuchi, Benard Omogo, Colin D Heyes

Abstract read
In one paragraph

Article in Nano letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hiroko TakeuchiDepartment of Chemistry and Biochemistry, University of Arkansas , 345 N. Campus Drive, Fayetteville, Arkansas 72701, United States.
Benard Omogo
Colin D Heyes

Funding

Center for Protein Structure and FunctionP30GM103450 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2012 to 2014
$3.2M
Monovalent Nanocrystals for Biomedical ImagingR21EB009802 · NIBIB · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI ADAMS, PAUL DAMIEN, GAWLEY, ROBERT E. · 2009 to 2010
$389k
NIBIB NIH HHS R21 EB009802NIBIB NIH HHS R21 EB009802-01NIGMS NIH HHS P30 GM103450
6 · The paper itself

Abstract

Coordinating ligands are widely used to vary the solubility and reactivity of nanoparticles for subsequent bioconjugation. Although long-term colloidal stability is enhanced by using bidentate coordinating ligands over monodentate ones, other properties such as nonspecific adsorption of target molecules and ligand exchange have not been quantified. In this study, we modified a near-infrared dye to serve as a highly sensitive reporter for nonspecific binding of thiolated target molecules to nanoparticle surfaces that are functionalized with monodentate or bidentate coordinated ligands. Specifically, we analyzed nonspecific binding mechanisms to quantum dots (QDs) by fitting the adsorption profiles to the Hill equation and the parameters are used to provide a microscopic picture of how ligand density and lability control nonspecific adsorption. Surprisingly, bidentate ligands are worse at inhibiting adsorption to QD surfaces at low target/QD ratios, although they become better as the ratio increases, but only if the nanoparticle surface area is large enough to overcome steric effects. This result highlights that a balance between ligand density and lability depends on the dentate nature of the ligands and controls how molecules in solution can coordinate to the nanoparticle surface. These results will have major implications for a range of applications in nanobiomedicine, bioconjugation, single molecule spectroscopy, self-assembly, and nano(photo)catalysis where both nonspecific and specific surface interactions play important roles. As an example, we tested the ability of monodentate and bidentate functionalized nanoparticles to resist nonspecific adsorption of IgG antibodies that contained free thiol groups at a 1:1 QD/IgG ratio and found that QDs with monodentate ligands did indeed result in lower nonspecific adsorption.

Indexed as

AdsorptionNanotechnologyAntibodiesImmunoglobulin GLigandsMetal NanoparticlesQuantum DotsSolubilitySulfhydryl CompoundsAntibodiesImmunoglobulin GLigandsSulfhydryl Compounds

Identifiers

PMID24016073
PMCPMC3938389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.